Personal Injury

July 26, 2010

Ex-Workers’ Lawsuit Blames Motorola for Birth Defects

A group of former Motorola workers and their children filed a lawsuit Friday against the Schaumburg-based company, claiming toxic substances used to make Motorola products caused serious birth defects in at least 30 children born to workers employed by the company since the 1960s.

The 71 plaintiffs filed the suit in Cook County Circuit Court. The suit claims Motorola knew the chemicals used to make semiconductors and computer chips in sterile “clean rooms” were toxic and had the potential to cause birth defects in children born to people exposed to the compounds.

Thirty children of former employees allegedly suffer from physical and developmental disabilities, including cerebral palsy, autism, spina bifida, sterility and brain malformations, the suit claims. LEEANN MATON, Chicago Sun-Times 07/26/2010

Read Article: Chicago Sun-Times

July 22, 2010

Lawsuit: Campus Police Didn’t Investigate Rape Claim

by Dr. Shezad Malik

A lawsuit has been filed against the Arizona Board of Regents by a former Arizona State student who claims that the university police department and disciplinary office failed to properly investigate her accusations that she was raped.

According to the police report, the woman reported the alleged incident the day after it occurred, and officers determined that she had not withdrawn consent during the sexual activity. The lawsuit, however, claims that the police department “refused to give the woman a forensic sexual assault examination,” and performed an inadequate investigation. The lawsuit seeks unspecified damages. Derek Quizon, Arizona Republic 07/13/2010
Read Article: Arizona Republic

July 21, 2010

Glaxo Said to Have Paid $1 Billion Over Paxil Suits

by Dr. Shezad Malik

GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements.

The settlements, which provide an average payout of more than $1.2 million to families of affected children, leave more than 100 birth-defect cases pending, the people said. Officials of Glaxo, the U.K.’s biggest drugmaker, said July 15 they set aside $2.4 billion to resolve litigation over Paxil and its Avandia diabetes drug.

Read full Bloomberg story here.

July 20, 2010

Court Files Indicate Settlement in Paxil Lawsuit

by Dr. Shezad Malik

A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.

Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The complaint said Nathan Berg died in 2004 because of a heart disorder caused by her use of the antidepressant Paxil while she was pregnant. WAYNE ORTMAN, AP , The Washington Post 07/20/2010
Read Article: The Washington Post

July 20, 2010

Paxil Birth Defect Dallas Attorney Update

by Dr. Shezad Malik

In 2005, the Food and Drug Administration (FDA) warned doctors about a study showing that babies born to women who took Paxil during the first trimester of pregnancy had a higher rate of major birth defects. The study, which involved 3,500 pregnant women, showed that those on Paxil were twice as likely to have a child with defects than women on other antidepressants.

The FDA put out a statement warning that “[h]ealthcare professionals are advised to carefully weigh the potential risks and benefits of using [Paxil] in women during pregnancy and to discuss these findings as well as treatment alternatives with their patients.”

At least 600 cases have been filed alleging that Paxil is responsible for congenital birth defects. GSK has also paid approximately $1 billion in settlements of Paxil-related cases not involving birth defects.

Read full story here.

July 20, 2010

Fatal Train Wreck In Illinois Prompts Lawsuit

by Dr. Shezad Malik

A lawsuit was filed against two northern railroad companies this week by the family of a Chicago woman who was hit by a train and killed.

Katie Ann Lunn died in the train accident earlier this year when an Amtrak train hit her SUV, which was stopped on the tracks in heavy traffic.

The lawsuit contends that the Illinois Central Railroad Co. and Wisconsin Central Ltd. failed “to ensure crossing-protection systems were functioning properly,” among other things, which would have prevented the accident. The suit is seeking unspecified damages. Jon Hilkevitch, Chicago Tribune 07/14/2010
Read Article: Chicago Tribune

July 19, 2010

Doctors Say It’s Already Over For Diabetes Drug Avandia

by Dr. Shezad Malik

In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia.

An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the final say on the committee’s recommendations and could decide within weeks.

Doctors already have given their verdict. Avandia prescriptions have plummeted since a study in The New England Journal of Medicine in May 2007 raised concerns about whether the drug increased heart attack risk.

Rule the full story here.

July 18, 2010

GSK to Take Charge of $2.36B Related to Paxil, Avandia.

by Dr. Shezad Malik

The New York Times (7/16, B2, Jolly, Harris) reports that UK pharmaceutical maker GlaxoSmithKline announced on July 15 that “it would take a second-quarter charge of $2.36 billion related to legal cases involving its drugs Avandia [rosiglitazone] and Paxil [paroxetine].”

This announcement comes one “day after an American medical advisory panel recommended that Avandia, a controversial diabetes drug, should either be withdrawn from the market or be severely restricted in its sales because it increases the risks of heart attacks.” According to GSK, “the charge announced Thursday, which will amount to about $2.1 billion after taxes, ‘includes provisioning for settled cases and an estimate for those cases which we have received and are still outstanding.'”

Read the full story here.

July 18, 2010

Natural Gas Company’s Natural Gas Disclosure Decision Could Change Fracking

by Dr. Shezad Malik

A Texas natural gas producer’s decision to voluntarily disclose the chemicals it injects into the ground could prompt other drillers to do the same, and pave the way for regulators to require such disclosure.

But Range Resources Corp.’s move also reflects the desire of industry to get out ahead of the issue to prevent federal regulation of the key drilling practice called hydraulic fracturing, or fracking. MIKE SORAGHAN, Greenwire, The New York Times 07/16/2010
Read Article: The New York Times

July 17, 2010

FDA: Avandia To Be Restricted

by Dr. Shezad Malik

An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sales should be severely restricted.

Avandia and its maker, GlaxoSmithKline, have recently come under fire for trial results that reveal that patients taking Avandia are at an increased risk for heart attacks.

A majority of the committee decided that if Glaxo wants to keep Avandia on the market, it must complete another clinical trial to prove it is safe.

FDA officials said they will consider the recommendations of the committee and make an official decision as soon as possible. Gardiner Harris, The New York Times 07/14/2010
Read Article: The New York Times